| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |